Canducid 70mg Injection

Reviews How to Use Benefits Uses Side Effects

Product Info

Prescription required	Yes
Marketer	Zyphar's Pharmaceuticals Pvt Ltd
Active Ingredient	Caspofungin (70mg)
Storage	Store in a refrigerator (2 - 8°C). Do not freeze.
Chemical Class	Echinocandins
Habit Forming	No
Therapeutic Class	ANTI INFECTIVES
Action Class	Fungal cell wall synthesis inhibitor (Echiocandins)
User Rating	4.2
User Reviews	330

FAQ

Is Canducid 70mg effective?

Canducid 70mg is effective if used in the dose and duration advised by your doctor. Do not stop taking it even if you see improvement in your condition. If you stop using Canducid 70mg too early, the symptoms may return or worsen.

What is Canducid 70mg used to treat?

Canducid 70mg is used to treat serious fungal as well as yeast infections in the blood, stomach, lungs, and food pipe (esophagus).

Is Canducid 70mg an antibiotic?

Yes, Canducid 70mg is an antifungal antibiotic. It kills the fungi and yeast causing serious infections and helps in clearing the infection.

What does Canducid 70mg target?

Canducid 70mg targets an essential component of the outermost layer (cell wall) of the fungus, called beta-(1,3)-D-glucan. This component is present in the Aspergillus species and Candida species but not present in mammalian cells. Canducid 70mg stops the synthesis of this component and this kills the fungus, inhibits further growth, thereby clearing the infection.

How is Canducid 70mg administered?

Canducid 70mg should be administered as an injection into a vein under the supervision of a trained healthcare professional or a doctor only usually once a day. It should be injected slowly over 1 hour and should not be self-administered. The dose will depend on the condition you are being treated for and will be decided by your doctor. Follow your doctor’s instructions carefully to get maximum benefit from Canducid 70mg.

What if you forget to take Canducid Injection?

If you miss a dose of Canducid 70mg, please consult your doctor.\n

Canducid 70mg Injection Reviews

Canducid 70mg is an antifungal medication. It is used in the treatment of severe fungal infections. It kills the fungi that cause these infections and thus provides relief.

Canducid 70mg is administered as an injection by a healthcare professional. Kindly do not self-administer. Do not skip any doses and finish the full course of treatment even if you feel better. Your doctor may monitor your liver function regularly during treatment.

Canducid 70mg may lead to a few common side effects like rash, decreased potassium level in the blood, fever, increased liver enzymes, chills, and diarrhea. You may also notice some injection site reactions like pain, swelling, or redness. Inform your doctor if these side effects persist for a longer duration. Please consult your doctor if you are pregnant, planning to conceive, or breastfeeding.

How Canducid 70mg Injection Works

Canducid 70mg kills fungus by preventing them from making their protective covering.

How to Use Canducid 70mg Injection

Your doctor or nurse will give you this medicine. Kindly do not self administer.

Uses of Canducid 70mg Injection

Severe fungal infections

Canducid 70mg Injection Side Effects

Safety Tips

Liver ^CAUTION

Canducid 70mg should be used with caution in patients with liver disease. Dose adjustment of Canducid 70mg may be needed. Please consult your doctor.Limited information is available on the use of Canducid 70mg in patients with the severe liver disease.

Breast feeding ^{SAFE IF PRESCRIBED}

Canducid 70mg is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.

Kidney ^{SAFE IF PRESCRIBED}

Canducid 70mg is safe to use in patients with kidney disease. No dose adjustment of Canducid 70mg is recommended.

Pregnancy ^{CONSULT YOUR DOCTOR}

Canducid 70mg may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Driving ^{CONSULT YOUR DOCTOR}

It is not known whether Canducid 70mg alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.

Alcohol ^{CONSULT YOUR DOCTOR}

It is not known whether it is safe to consume alcohol with Canducid 70mg. Please consult your doctor.

Quick Tips

Inform your doctor if you are pregnant, planning pregnancy or breastfeeding.
Your doctor may check your liver function regularly. Inform your doctor if you develop abdominal pain, loss of appetite, darkened urine or yellowing of the eyes or skin (jaundice).
Do not skip any doses and finish the full course of treatment even if you feel better.
Canducid 70mg is given as a slow drip into vein (IV infusion) under the supervision of a doctor.
Your doctor may check your liver function regularly. Inform your doctor if you develop abdominal pain, loss of appetite, darkened urine or yellowing of the eyes or skin (jaundice).
Inform your doctor if you are pregnant, planning pregnancy or breastfeeding.
Do not skip any doses and finish the full course of treatment even if you feel better.
Canducid 70mg is given as a slow drip into vein (IV infusion) under the supervision of a doctor.

References

Caspofungin. White House Station, New Jersey: Merck & Co.; 2001.
Caspofungin acetate. Hoddesdon, Hertfordshire: Merck Sharp & Dohme Limited; 2001 [revised 08 Aug. 2018].
Central Drugs Standard Control Organisation (CDSCO).
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 216-17.
Sheppard D, Lampiris HW. Antifungal Agents. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 841.
Bennett JE. Antifungal Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. New York, New York: McGraw-Hill Medical; 2011. pp. 1583-84.